SHANGHAI MODEL ORGANISMS CENTER, INC. — Investor Relations & Filings

Shanghai Model Organisms Center, Inc. (SMOC) specializes in the research, development, and application of genetically modified animal models for life science research and drug discovery. The company utilizes advanced gene-editing technologies, including CRISPR/Cas9 and embryonic stem cell targeting, to produce a wide range of genetically engineered mouse models (GEMMs), such as knockout, knockin, and conditional knockout strains. SMOC maintains an extensive repository of standardized models and offers customized model generation services tailored to specific research needs. Key offerings include humanized mouse models for immuno-oncology and inflammation studies, as well as comprehensive phenotyping and preclinical efficacy testing services. Serving a global clientele of pharmaceutical firms and academic institutions, the company provides critical tools for understanding disease mechanisms and accelerating therapeutic development.